Magnetic Resonance Elastography for Brain Cancer
Trial Summary
What is the purpose of this trial?
This clinical trial tests whether a new imaging technique called magnetic resonance elastography (MRE) is useful in determining the consistency of brain tumors and whether this could be used to guide surgical planning and choice of approach (the type of surgery that is needed) for patients with brain tumors. Comparing MRE with the typical magnetic resonance imaging (MRI) scan may help researchers assess the quality, reliability, and diagnostic utility of this scan when evaluating brain tumors.
Research Team
Mark S Shiroishi, MD
Principal Investigator
University of Southern California
Eligibility Criteria
This trial is for adults over 18 with brain tumors who are scheduled for surgical removal at Keck Medical Center of USC. It's not suitable for those unable to undergo MRE or MRI, including individuals with metal implants, claustrophobia, a large body size, minors, pregnant women, state wards, and prisoners.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Magnetic Resonance Elastography
Magnetic Resonance Elastography is already approved in United States, European Union for the following indications:
- Diagnostic imaging for gliomas
- Assessment of tissue stiffness in radiation necrosis and recurrent glioma
- Diagnostic imaging for gliomas
- Assessment of tissue stiffness in radiation necrosis and recurrent glioma
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
National Cancer Institute (NCI)
Collaborator